Meta分析整体思路概览

2018-03-02 MedSci MedSci原创

Meta分析,中文称“荟萃分析”。它是循证医学重要的研究方法和最佳证据来源之一,是当临床科研工作者必备的研究方法和技术。掌握Meta分析有助于提高临床研究设计的质量和发表高水平学术论文的能力,也是许多大型临床研究的前奏,以及临床研究创新的来源。 Meta分析是一种系统性评价方法,目前大部分多中心RCT(随机对照试验)都是国外研究机构发表,他们一般在进行临床研究的同时,已经将其meta分析的文

Meta分析,中文称“荟萃分析”。它是循证医学重要的研究方法和最佳证据来源之一,是当临床科研工作者必备的研究方法和技术。掌握Meta分析有助于提高临床研究设计的质量和发表高水平学术论文的能力,也是许多大型临床研究的前奏,以及临床研究创新的来源。

Meta分析是一种系统性评价方法,目前大部分多中心RCT(随机对照试验)都是国外研究机构发表,他们一般在进行临床研究的同时,已经将其meta分析的文章也顺带做了。但在国内,虽然很多人沉迷做meta,但由于缺乏好的idea和临床研究数据,很难做出高质量的分析。因此,在做Meta分析之前一定要有好的切入点,即要有一个好的选题,这往往决定你的文章质量。

Meta分析的基本框架

Meta分析的主要目的是描述相似研究之间的差异,若差异不是很大,对积累数据进行定量总结。研究的对象是每个研究(分析的单位),由于Meta分析为观察性研究,因此必须将误差和偏移量最小化,寻找可重复性的方法,包括撰写方案等。

为什么进行RCT试验的Meta分析?

上帝给予我们随机化方法,使我们能够发现大多数治疗的些许疗效--by Robert Califf,MD

1,提高统计学的把握度和精度


★需要找到小的但是临床治疗效果显着的研究

★存在一些小的不确定的RCT研究

--经常发生在研究的早期阶段

--初次试验是小的预实验

★识别药物的不良反应

--对于单个的RCT研究不良反应经常是少见的和统计学无显着差异的

--少见的但是严重的不良反应可能会终止干预/药物

2,探索和解释研究结果的异质性

★RCT结果的不一致常导致缺乏共识

★对于识别变异性(异质性)的原因很重要

★借助于meta分析或者更高级的meta回归分析

--meta分析能够发现研究之间存在变异的线索(比如:与试验纳入标准,研究中心,地理位置,时间段,疾病的严重程度等相关的变异

★识别异质性可能帮助找出治疗更有效(或更无效)的亚组人群

3,形成共识,提高外推性

★更精确的评价形成共识可以用来:更新临床指南,更加广泛的实施有效的治疗,停止或避免有害的治疗。

★如果meta分析显示治疗效果在不同的试验人群,干预的类型或者剂量之间是一致的,能够提高外推性。

4,更好的发表亚组效果

★亚组分析指的是检验一种治疗在不同类型(亚组)的患者中疗效是否一致

★对于单个试验来说,亚组分析是明显不可靠的:

--多重比较的问题-多重的统计学检验会产生假阳性结果

--单个比较的把握度低(由于样本量小)

--亚组可能不具有可比性(混杂问题)

5,指导未来的RCT研究设计

★Meta分析能够为以后更大的明确的试验设计提供详细的信息

诊断标准,试验合格标准,对照组应答率,干预的预期效果大小及随访时间的长度

★Meta分析有助于识别差异

★由于不同研究的方法学差别太大,因此不太可能合并实验结果,不同人群,不同治疗,不同疾病定义,不同的结果测量标准

★Meta分析能够为将来试验提供更统一的方法

★Meta分析看似简单但是需要详细的计划和充足的资源(时间就是金钱)

掌握Meta分析的关键步骤

1,提出一个可回答的研究问题(PICO)

★Meta分析需要一个可回答的研究问题

★以一个一般的问题或假设开始

--缺血性脑卒中患者急性期给予他汀能改善结局吗?

★使用pico原则来精炼问题:

--P=缺血性卒中的患者

--I=急性期给予他汀

--C=没有给予他汀的患者

--O=死亡,残疾(BI)和功能(mRS)

2,设计研究方案

★像任何其他类型的研究一样,在开始meta分析之前,详细的研究方案是至关重要的。

★研究方案应明确的描述:

--具体的研究问题/目的

--研究人群

--纳入和排除标准(应用于单个研究)

--暴露(治疗)和结局测量措施的定义

--检索策略(检索词,数据库来源,只有公开发表的研究或者也包括灰色文献及语种限制)

--评价研究质量

--数据提取和数据录入的方法

--统计分析(随即或固定效应模型,预先设定亚组,敏感性分析)

★预先规定越详细,事后分析产生偏倚的可能性越小

3,检索相关的RCT研究

MEDLINE由美国政府(美国国立医学图书馆,美国国立卫生研究院)创建,覆盖生物医学且主要集中于临床医学,包括来自美国和其他70个国家的约5500个期刊,2000万篇文章(每天更新2000-4000篇文章),文献可追溯到1946年,超过80%的引用包括作者提供的英文摘要,也可通过pubmed获取。

★检索资源/数据库

Cochrane图书馆--CENTRAL对照试验注册中心:国际循证医学写作组共收录多于500000个试验,是检索已发表的随机试验的最佳网址

★其他资源

--EMBASE(摘要数据库),ISI Web of Science,Scopus, Ovid, ProQuest.

★哪些数据库用来检索中文发表的文章?

中国知网(CNKI),中文科技期刊数据库,万方数据库等等

4、检索结果筛选

★初次筛选(通过题目确定关联):初次检索的使用题目确定潜在的关联,例如:300条记录,150条可通过题目提示文章可能相关

★二次筛选(通过摘要确定相关性):通过阅读在线摘要确定相关性,例如:120/150可能相关的文章具有在线摘要,80篇可能相关。

★最终筛选(确定最终标准):获取所有的110篇(80+30无摘要文章)全文,应用纳入/合格标准

Meta分析的局限性

★研究者偏倚

--潜在的利益冲突

--潜在的纳入哪项研究的控制

--可能在研究发现/结论摆动

--准备研究方案的重要性

★研究选择偏倚

--来自现有数据库的相关问题:没有完美的检索策略

--灰色文献

--语种限制

★发表偏倚

--Meta分析的目的是总结全部现有的证据

--但是并不是所有已完成的研究都已发表

--哪种类型的研究不能发表?

阴性或中立的发现,尤其是小样本的研究

结果和目前传统观点相反的研究

来自企业的没有得出阳性结果的研究

★作者和期刊编辑都会导致这个问题

★试验注册的原理:如果没有注册试验,将不能在任何一个核心期刊上发表,所有的核心医学期刊(ICMJE)需要试验在开始之前完成注册。

Meta分析的关键评价

★结果是否有效?怎样评价研究的效果?

★结果是什么?

★如何将研究结果应用于医疗?

梅斯医学将于2018年3月10-11日在上海梅斯总部特推出最新一期加强版的Meta分析初级班培训班。授课老师是具有多年工作经验和大量案例操作的讲师构成,课程不仅教会您meta分析的流程和框架,还会教会您怎么去操作软件,怎么把数据收集起来、怎么录入数据、怎么去提取、偏移、分析等,老师同时也会针对每个人的问题做专门解答哦。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1896282, encodeId=0a351896282d5, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 28 12:36:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887845, encodeId=0d75188e84536, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Wed May 23 12:36:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320801, encodeId=7c1732080119, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af022225040, createdName=1210f606m37暂无昵称, createdTime=Sat Jun 02 09:34:15 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298942, encodeId=8b4f29894253, content=认真学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Fri Mar 23 10:18:26 CST 2018, time=2018-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293314, encodeId=7c182933141d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Rezf5JUZM2rFDmSx5Nkv2UFmhSunJlo5PmTYvT6YRniaMfZZJhvGGTFQCExpJm6ZfPFf7n9PNicFSqPIm9cbFkLQ/132, createdBy=1a7f2284023, createdName=荆棘没有刺, createdTime=Mon Mar 05 22:01:45 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292856, encodeId=409929285659, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdgSW0vVibEHQRlKXLlvMibvcHmy5ibwM7Luib2am6ywX6FqBrXibF8k7JVEzriaOSghltmYz1nomRd6TgSp2Yj9xHGAY/0, createdBy=9b2f2045808, createdName=haige, createdTime=Sun Mar 04 08:45:06 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292739, encodeId=b6b2292e3921, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Sun Mar 04 01:09:03 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292635, encodeId=cc7d292635ea, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Sat Mar 03 16:40:48 CST 2018, time=2018-03-03, status=1, ipAttribution=)]
    2018-04-28 一闲
  2. [GetPortalCommentsPageByObjectIdResponse(id=1896282, encodeId=0a351896282d5, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 28 12:36:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887845, encodeId=0d75188e84536, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Wed May 23 12:36:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320801, encodeId=7c1732080119, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af022225040, createdName=1210f606m37暂无昵称, createdTime=Sat Jun 02 09:34:15 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298942, encodeId=8b4f29894253, content=认真学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Fri Mar 23 10:18:26 CST 2018, time=2018-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293314, encodeId=7c182933141d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Rezf5JUZM2rFDmSx5Nkv2UFmhSunJlo5PmTYvT6YRniaMfZZJhvGGTFQCExpJm6ZfPFf7n9PNicFSqPIm9cbFkLQ/132, createdBy=1a7f2284023, createdName=荆棘没有刺, createdTime=Mon Mar 05 22:01:45 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292856, encodeId=409929285659, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdgSW0vVibEHQRlKXLlvMibvcHmy5ibwM7Luib2am6ywX6FqBrXibF8k7JVEzriaOSghltmYz1nomRd6TgSp2Yj9xHGAY/0, createdBy=9b2f2045808, createdName=haige, createdTime=Sun Mar 04 08:45:06 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292739, encodeId=b6b2292e3921, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Sun Mar 04 01:09:03 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292635, encodeId=cc7d292635ea, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Sat Mar 03 16:40:48 CST 2018, time=2018-03-03, status=1, ipAttribution=)]
    2018-05-23 guojianrong
  3. [GetPortalCommentsPageByObjectIdResponse(id=1896282, encodeId=0a351896282d5, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 28 12:36:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887845, encodeId=0d75188e84536, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Wed May 23 12:36:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320801, encodeId=7c1732080119, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af022225040, createdName=1210f606m37暂无昵称, createdTime=Sat Jun 02 09:34:15 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298942, encodeId=8b4f29894253, content=认真学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Fri Mar 23 10:18:26 CST 2018, time=2018-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293314, encodeId=7c182933141d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Rezf5JUZM2rFDmSx5Nkv2UFmhSunJlo5PmTYvT6YRniaMfZZJhvGGTFQCExpJm6ZfPFf7n9PNicFSqPIm9cbFkLQ/132, createdBy=1a7f2284023, createdName=荆棘没有刺, createdTime=Mon Mar 05 22:01:45 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292856, encodeId=409929285659, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdgSW0vVibEHQRlKXLlvMibvcHmy5ibwM7Luib2am6ywX6FqBrXibF8k7JVEzriaOSghltmYz1nomRd6TgSp2Yj9xHGAY/0, createdBy=9b2f2045808, createdName=haige, createdTime=Sun Mar 04 08:45:06 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292739, encodeId=b6b2292e3921, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Sun Mar 04 01:09:03 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292635, encodeId=cc7d292635ea, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Sat Mar 03 16:40:48 CST 2018, time=2018-03-03, status=1, ipAttribution=)]
    2018-06-02 1210f606m37暂无昵称

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1896282, encodeId=0a351896282d5, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 28 12:36:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887845, encodeId=0d75188e84536, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Wed May 23 12:36:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320801, encodeId=7c1732080119, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af022225040, createdName=1210f606m37暂无昵称, createdTime=Sat Jun 02 09:34:15 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298942, encodeId=8b4f29894253, content=认真学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Fri Mar 23 10:18:26 CST 2018, time=2018-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293314, encodeId=7c182933141d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Rezf5JUZM2rFDmSx5Nkv2UFmhSunJlo5PmTYvT6YRniaMfZZJhvGGTFQCExpJm6ZfPFf7n9PNicFSqPIm9cbFkLQ/132, createdBy=1a7f2284023, createdName=荆棘没有刺, createdTime=Mon Mar 05 22:01:45 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292856, encodeId=409929285659, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdgSW0vVibEHQRlKXLlvMibvcHmy5ibwM7Luib2am6ywX6FqBrXibF8k7JVEzriaOSghltmYz1nomRd6TgSp2Yj9xHGAY/0, createdBy=9b2f2045808, createdName=haige, createdTime=Sun Mar 04 08:45:06 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292739, encodeId=b6b2292e3921, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Sun Mar 04 01:09:03 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292635, encodeId=cc7d292635ea, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Sat Mar 03 16:40:48 CST 2018, time=2018-03-03, status=1, ipAttribution=)]
    2018-03-23 张新亮1853311252142e2fm

    认真学习了.谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1896282, encodeId=0a351896282d5, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 28 12:36:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887845, encodeId=0d75188e84536, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Wed May 23 12:36:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320801, encodeId=7c1732080119, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af022225040, createdName=1210f606m37暂无昵称, createdTime=Sat Jun 02 09:34:15 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298942, encodeId=8b4f29894253, content=认真学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Fri Mar 23 10:18:26 CST 2018, time=2018-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293314, encodeId=7c182933141d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Rezf5JUZM2rFDmSx5Nkv2UFmhSunJlo5PmTYvT6YRniaMfZZJhvGGTFQCExpJm6ZfPFf7n9PNicFSqPIm9cbFkLQ/132, createdBy=1a7f2284023, createdName=荆棘没有刺, createdTime=Mon Mar 05 22:01:45 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292856, encodeId=409929285659, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdgSW0vVibEHQRlKXLlvMibvcHmy5ibwM7Luib2am6ywX6FqBrXibF8k7JVEzriaOSghltmYz1nomRd6TgSp2Yj9xHGAY/0, createdBy=9b2f2045808, createdName=haige, createdTime=Sun Mar 04 08:45:06 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292739, encodeId=b6b2292e3921, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Sun Mar 04 01:09:03 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292635, encodeId=cc7d292635ea, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Sat Mar 03 16:40:48 CST 2018, time=2018-03-03, status=1, ipAttribution=)]
    2018-03-05 荆棘没有刺

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1896282, encodeId=0a351896282d5, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 28 12:36:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887845, encodeId=0d75188e84536, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Wed May 23 12:36:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320801, encodeId=7c1732080119, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af022225040, createdName=1210f606m37暂无昵称, createdTime=Sat Jun 02 09:34:15 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298942, encodeId=8b4f29894253, content=认真学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Fri Mar 23 10:18:26 CST 2018, time=2018-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293314, encodeId=7c182933141d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Rezf5JUZM2rFDmSx5Nkv2UFmhSunJlo5PmTYvT6YRniaMfZZJhvGGTFQCExpJm6ZfPFf7n9PNicFSqPIm9cbFkLQ/132, createdBy=1a7f2284023, createdName=荆棘没有刺, createdTime=Mon Mar 05 22:01:45 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292856, encodeId=409929285659, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdgSW0vVibEHQRlKXLlvMibvcHmy5ibwM7Luib2am6ywX6FqBrXibF8k7JVEzriaOSghltmYz1nomRd6TgSp2Yj9xHGAY/0, createdBy=9b2f2045808, createdName=haige, createdTime=Sun Mar 04 08:45:06 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292739, encodeId=b6b2292e3921, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Sun Mar 04 01:09:03 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292635, encodeId=cc7d292635ea, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Sat Mar 03 16:40:48 CST 2018, time=2018-03-03, status=1, ipAttribution=)]
    2018-03-04 haige

    学习了!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1896282, encodeId=0a351896282d5, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 28 12:36:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887845, encodeId=0d75188e84536, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Wed May 23 12:36:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320801, encodeId=7c1732080119, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af022225040, createdName=1210f606m37暂无昵称, createdTime=Sat Jun 02 09:34:15 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298942, encodeId=8b4f29894253, content=认真学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Fri Mar 23 10:18:26 CST 2018, time=2018-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293314, encodeId=7c182933141d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Rezf5JUZM2rFDmSx5Nkv2UFmhSunJlo5PmTYvT6YRniaMfZZJhvGGTFQCExpJm6ZfPFf7n9PNicFSqPIm9cbFkLQ/132, createdBy=1a7f2284023, createdName=荆棘没有刺, createdTime=Mon Mar 05 22:01:45 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292856, encodeId=409929285659, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdgSW0vVibEHQRlKXLlvMibvcHmy5ibwM7Luib2am6ywX6FqBrXibF8k7JVEzriaOSghltmYz1nomRd6TgSp2Yj9xHGAY/0, createdBy=9b2f2045808, createdName=haige, createdTime=Sun Mar 04 08:45:06 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292739, encodeId=b6b2292e3921, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Sun Mar 04 01:09:03 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292635, encodeId=cc7d292635ea, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Sat Mar 03 16:40:48 CST 2018, time=2018-03-03, status=1, ipAttribution=)]
    2018-03-04 jihuaijun1112

    学习学习学习

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1896282, encodeId=0a351896282d5, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 28 12:36:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887845, encodeId=0d75188e84536, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Wed May 23 12:36:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320801, encodeId=7c1732080119, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af022225040, createdName=1210f606m37暂无昵称, createdTime=Sat Jun 02 09:34:15 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298942, encodeId=8b4f29894253, content=认真学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Fri Mar 23 10:18:26 CST 2018, time=2018-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293314, encodeId=7c182933141d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Rezf5JUZM2rFDmSx5Nkv2UFmhSunJlo5PmTYvT6YRniaMfZZJhvGGTFQCExpJm6ZfPFf7n9PNicFSqPIm9cbFkLQ/132, createdBy=1a7f2284023, createdName=荆棘没有刺, createdTime=Mon Mar 05 22:01:45 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292856, encodeId=409929285659, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdgSW0vVibEHQRlKXLlvMibvcHmy5ibwM7Luib2am6ywX6FqBrXibF8k7JVEzriaOSghltmYz1nomRd6TgSp2Yj9xHGAY/0, createdBy=9b2f2045808, createdName=haige, createdTime=Sun Mar 04 08:45:06 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292739, encodeId=b6b2292e3921, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Sun Mar 04 01:09:03 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292635, encodeId=cc7d292635ea, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Sat Mar 03 16:40:48 CST 2018, time=2018-03-03, status=1, ipAttribution=)]
    2018-03-03 sunfeifeiyang

    学习

    0

相关资讯

JAMA Oncol:免疫检查点抑制剂二线治疗NSCLC预后因素Meta分析

免疫检查点抑制剂替代多西他赛成为晚期NSCLC的标准二线治疗,但缺乏临床和分子特征的预后数据。纳入免疫检查点抑制剂(纳武单抗、派姆单抗或atezolizumab)对比多西他赛的随机对照研究。收集试验名称、发表时间、患者临床病理特征、化疗类型、免疫检查点抑制剂类型。

东南大学医学院马根山等研究称,这种维生素竟然可预防对比剂肾病

对比剂肾病在临床并不少见,少用点对比剂和水化疗法是普遍认可的防治措施。近日,东南大学医学院马根山、唐庚等进行的Meta分析还显示,用点维生素,尤其是维生素C也有助于降低对比剂肾病的发生风险。

Int J Oral Surg:口腔癌的治疗方式的选择:边缘或节段性切除

对于大多数口腔癌来说,手术是初步明确的治疗方式。在颌骨可能涉及的口腔癌肿瘤切除方面,最重要的是下颌骨的处理。

高影响因子的meta分析应该是这样的

高影响因子的meta分析应该是这样的对于meta分析,大家都再熟悉不过了,尤其是临床医生,尤其是做临床科研的。meta分析的价值是毋庸置疑的。高质量的meta分析,对于临床决策是至关重要的。现在发表meta分析的作者越来越多,但是高质量meta分析还是有限。所以meta分析的质量还有待进一步的提高。但是目前也不乏发表高质量meta分析的期刊,包括内科年鉴,if17+,BMJ等权威期刊。但是如何发表

ANN Oncol:惊!!肥胖会导致癌症 ??

肥胖不仅有悖于国人的审美,还会导致诸多慢性病。在一些研究中表明体重指数(BMI)与某些部位(如消化系统)癌症发病风险呈相关,但与其他部位癌症的关系尚无统一结论。

EUR J Cancer:基于随机试验的meta分析:贝伐单抗在实体瘤中的作用

贝伐单抗是一种人源化的单克隆抗体,能够抑制循环血管内皮生长因子与其受体的结合。 迄今为止,美国FDA已经批准贝伐单抗用于治疗多种实体瘤。为了评估以贝伐单抗为基础的治疗方案对这些晚期实体瘤患者的影响,研究人员进行了一项meta分析,研究人员对所有的随机试验(II期或III期)中贝伐单抗、安慰剂和其他抗肿瘤药物进行了对比。